Keywords: schering, ag, sees, 1st-qtr, net, profit, rise
Schering AG sees 1st-qtr net profit rise 11%, with strong sales growth in USA
Article | 25 April 2005
Berlin, Germany-headquartered drugmaker Schering AG posted sales of 1.21 billion euros ($1.58 billion) for the first quarter of 2005, up 4%, or a currency-adjusted ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
